• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.67% Nasdaq Up 1.47%

    NeurogesX, Inc. (NGSX)

    -Other OTC
    0.01 0.00(0.00%) May 22, 2:19PM EDT
    |Pre-Market : 0.28 0.00 (0.00%) 4:13PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:0.01
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:1.00
    Beta:1.52
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:0.00 - 0.02
    Volume:0
    Avg Vol (3m):N/A
    Market Cap:233.33K
    P/E (ttm):N/A
    EPS (ttm):-0.96
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    • No Headlines available for NGSX at this time.

    Comparison

    Symbol% ChgMkt Cap
    NGSX 0.00%233.33K
    LLYUp 0.79%79.32B
    ENDPUp 0.29%14.91B
    PFEUp 0.56%211.21B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (0-00-31) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    NeurogesX, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel non-opioid, pain management therapies to address unmet medical needs. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback